Renal Disease

Disease State Hub

Videos

Video

Video

The Management of Patients With Primary Hyperoxaluria

12/20/2023

James Matera, DO

In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...

12/20/2023

Research Summaries

FDA ALERT

FDA Approves Nedosiran for Patients 9 Years of Age and Older With Primary Hyperoxaluria Type 1

01/29/2024

Anthony Calabro, MA

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

01/29/2024

Endocrinology

FDA Approves New Drug for Cushing Disease

03/09/2020

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

03/09/2020

Renal Disease

Model Predicts ESLD Among Patients with HIV

03/08/2019

A predictive model could be used to help risk of end-stage liver disease in people living with HIV, according to recent research.

03/08/2019

Kidney Disease

Childhood Kidney Disease May Raise Adulthood ESRD Risk

02/01/2018

The authors of a new study investigated the long-term risk for adulthood end-stage renal disease among individuals who had childhood kidney disease that resolved prior to adolescence.

02/01/2018

Renal Disease

Unplanned Readmissions Occur in One-Fourth of ESRD Patients

09/29/2017

Patients with end stage renal disease on hemodialysis experience high 30-day unplanned readmissions. Using a large administrative database, researchers investigated reasons for initial admission and...

09/29/2017

April 2024

Current Issue

April 2024

Volume 64

Issue 4